Screener
Cytokinetics CYTK Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaboration Revenues | $3.29M+36.2% | $2.64M+67.0% | $2.76M+43.0% | $1.94M+318% | $2.42M+870% | |
| Development And Commercial Milestones | $10M— | —— | —— | —— | —— | |
| License And Milestone Revenues | $11.9M-81.5% | $11.93M— | $15M0.0% | $0— | $64.35M— |
FAQ
- How does Cytokinetics break its business down?
- Cytokinetics (CYTK) reports revenue by product across 3 parts — Collaboration Revenues, Development And Commercial Milestones and License And Milestone Revenues. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytokinetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytokinetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
